mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021 | 714 | 2021 |
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19 LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, ... Science immunology 6 (57), eabf7570, 2021 | 192 | 2021 |
Ferroptosis of tumour neutrophils causes immune suppression in cancer R Kim, A Hashimoto, N Markosyan, VA Tyurin, YY Tyurina, G Kar, S Fu, ... Nature 612 (7939), 338-346, 2022 | 158 | 2022 |
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen RA Evans, MS Diamond, AJ Rech, T Chao, MW Richardson, JH Lin, ... JCI insight 1 (14), 2016 | 152 | 2016 |
Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2) N Markosyan, J Li, YH Sun, LP Richman, JH Lin, F Yan, L Quinones, ... The Journal of clinical investigation 129 (9), 3594-3609, 2019 | 136 | 2019 |
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer SB Kemp, N Cheng, N Markosyan, R Sor, IK Kim, J Hallin, J Shoush, ... Cancer discovery 13 (2), 298-311, 2023 | 128 | 2023 |
Mammary Carcinoma Cell Derived Cyclooxygenase 2 Suppresses Tumor Immune Surveillanceby Enhancing Intratumoral Immune Checkpoint Activity N Markosyan, EP Chen, RA Evans, V Ndong, RH Vonderheide, EM Smyth Breast Cancer Research 15, 1-13, 2013 | 73 | 2013 |
Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function EP Chen, N Markosyan, E Connolly, JA Lawson, X Li, GR Grant, ... Carcinogenesis 35 (8), 1788-1797, 2014 | 57 | 2014 |
Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle N Markosyan, DM Duffy Endocrinology 150 (1), 435-444, 2009 | 52 | 2009 |
Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors N Markosyan, EP Chen, VN Ndong, Y Yao, CJ Sterner, LA Chodosh, ... Carcinogenesis 32 (10), 1441-1449, 2011 | 51 | 2011 |
Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization C Alanio, A Verma, D Mathew, S Gouma, G Liang, T Dunn, DA Oldridge, ... The Journal of infectious diseases 226 (3), 463-473, 2022 | 48 | 2022 |
Signaling through FcγRIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19 SA Apostolidis, A Sarkar, HM Giannini, RR Goel, D Mathew, A Suzuki, ... Frontiers in immunology 13, 834988, 2022 | 46 | 2022 |
Primate granulosa cell response via prostaglandin E2 receptors increases late in the periovulatory interval N Markosyan, BL Dozier, FA Lattanzio, DM Duffy Biology of reproduction 75 (6), 868-876, 2006 | 30 | 2006 |
Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts S Ibrahim, A McCartney, N Markosyan, EM Smyth Arteriosclerosis, thrombosis, and vascular biology 33 (1), 60-66, 2013 | 20 | 2013 |
Estrogen promotes luteolysis by redistributing prostaglandin F2a receptors within primate luteal cells SO Kim, N Markosyan, GJ Pepe, DM Duffy Reproduction 149 (5), 453-464, 2015 | 19 | 2015 |
Targeting COX-2 abrogates mammary tumorigenesis: Breaking cancer-associated suppression of immunosurveillance N Markosyan, EP Chen, EM Smyth Oncoimmunology 3 (6), e29287, 2014 | 17 | 2014 |
Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer. Cancer Discov. 2023; 13: 298–311. doi: 10.1158/2159-8290 SB Kemp, N Cheng, N Markosyan, R Sor, IK Kim, J Hallin, J Shoush, ... CD-22-1066.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 14 | |
Eicosanoids in Cancer N Markosyan, EM Smyth, P Patrignani, E Ricciotti Frontiers in Pharmacology 12, 765214, 2021 | 1 | 2021 |
mPGES1 deletion and the mechanisms of tumor growth suppression N Markosyan, A Rech, RH Vonderheide, GA FitzGerald, EM Smyth Cancer Research 75 (15_Supplement), 469-469, 2015 | 1 | 2015 |
Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing anti-tumor immunity N Markosyan, I Kim, C Arora, N Cheng, E Schechter, J Tobias, B Stanger, ... Cancer Research 84 (6_Supplement), 4985-4985, 2024 | | 2024 |